Atherosclerotic disease is the leading cause of death in
0% and non-HDL-C by 3.2%, while increasing HDL-C by 3.3% from baseline (Table 1). After the intervention, there was a significant decrease in TG and non-HDL-C, and a significant increase in HDL-C, without significant changes in either TC or LDL-C (by a paired t-test; significant levels, p< 0.05). Our lifestyle intervention thus produced an improvement in serum lipoprotein-lipid profiles, when we focused on non-HDL-C rather than TC or LDL-C. In our results, the significant reduction in non-HDL-C seemed to be caused in great part by the reduction in triglycerides (TGs), implying the significance of not only non-HDL-C but also of TG levels on the evaluation of HECs. However, some studies have recently indicated that non-HDL-C is a better predictor of cardiovascular diseases than LDL-C, regardless of TC, LDL-C or TG levels (1, 3-5). The clinical implications of non-HDL-C are strongly suggested in the Japanese population (2, 3). Taking these previous reports into account, although there has not been enough evidence on the prognostic utility of non-HDL-C in HECs, non-HDL-C might be a somewhat better potential atherogenic index than TGs, and a much better index than LDL-C even at relatively low TG levels as in
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